- In this study, all patients were in cardiogenic shock and on at least 2 pressors.
- Using the right subclavian artery, heart failure patients experienced an improvement in end organ function and hemodynamic stability. The device was placed via cutdown through an 8 mm vascular graft.
- A survival-to-discharge rate of 62.5% and bridge-to-success rate of 70.8% were reported for patients receiving Impella 5.0™ support using the right subclavian artery.
A recent retrospective review published in The Ochsner Journal
reveals advantages to using the right subclavian artery (RSA) for the insertion of Impella 5.0™ in the management of acute decompensated heart failure (ADHF). This synopsis provides a brief overview of how this technique may benefit end organ function in ADHF patients while improving left ventricular unloading and time to recovery. Continue readingThe Insertion of Impella 5.0™ in the Right Subclavian Artery for Treatment of Acute Decompensated Heart Failure